These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A defect in platelet aggregation in Bartter's syndrome. Stoff JS, Stemerman M, Steer M, Salzman E, Brown RS. Am J Med; 1980 Feb; 68(2):171-80. PubMed ID: 6243857 [Abstract] [Full Text] [Related]
4. Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. Di Virgilio F, Calò L, Cantaro S, Favaro S, Piccoli A, Borsatti A. Clin Sci (Lond); 1987 Apr; 72(4):483-8. PubMed ID: 3829597 [Abstract] [Full Text] [Related]
6. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome. Horký K, Schreiber V, Dvoráková J. Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182 [Abstract] [Full Text] [Related]
7. [Long-term captopril therapy of 3 sisters with Bartter's syndrome]. Volpi A, Meroni M, Battini G, Torri-Tarelli L, Conte F, Ferrario G, Giordano F, Tommasi A, Fabbri C, Sessa A. Minerva Urol Nefrol; 1988 Jul; 40(1):61-6. PubMed ID: 3051444 [No Abstract] [Full Text] [Related]
8. Increased sodium-lithium countertransport in red cells of patients with Bartter's syndrome. Mattioli M, Delva P, Lechi C, Minuz P, Lechi A, Scuro LA. J Endocrinol Invest; 1984 Feb; 7(1):61-3. PubMed ID: 6715799 [Abstract] [Full Text] [Related]
10. Platelet calmodulin concentration in essential hypertension and in Bartter's syndrome. Calò L, Cantaro S, Vianello A, Favaro S, Borsatti A. Am J Nephrol; 1986 Feb; 6 Suppl 1():60-2. PubMed ID: 3103446 [No Abstract] [Full Text] [Related]
11. Effect of captopril in Bartter's syndrome. Hené RJ, Koomans HA, Boer P, Dorhout Mees EJ. Nephron; 1983 Feb; 35(4):275. PubMed ID: 6358925 [No Abstract] [Full Text] [Related]
12. Atrial natriuretic peptide in Bartter's syndrome. Yamada K, Tajima K, Moriwaki K, Tarui S, Miyata A, Kangawa K, Matsuo H. Lancet; 1986 Feb 01; 1(8475):273. PubMed ID: 2868282 [No Abstract] [Full Text] [Related]
13. Neutrophil function in Bartter's syndrome. Lapointe N, Samson J, O'Regan S. Prostaglandins Med; 1981 Jun 01; 6(6):647-55. PubMed ID: 6267641 [Abstract] [Full Text] [Related]
15. Correction of hypokalemia corrects the abnormalities in erythrocyte sodium transport in Bartter's syndrome. Korff JM, Siebens AW, Gill JR. J Clin Invest; 1984 Nov 01; 74(5):1724-9. PubMed ID: 6501567 [Abstract] [Full Text] [Related]
17. Indomethacin and atrial natriuretic peptide in Bartter's syndrome. Gordon RD, Tunny TJ, Klemm SA. N Engl J Med; 1986 Aug 14; 315(7):459. PubMed ID: 2942775 [No Abstract] [Full Text] [Related]
18. Is the platelet defect in Bartter's syndrome associated with a plasma prostaglandin? MacIntyre DE, Smith M, Levine L, Stoff JS, Stemerman M, Steer ML, Salzman EW, Brown RS. Adv Prostaglandin Thromboxane Res; 1980 Aug 14; 7():1199-202. PubMed ID: 7369031 [No Abstract] [Full Text] [Related]
19. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T. Lancet; 2002 Aug 31; 360(9334):692-4. PubMed ID: 12241879 [Abstract] [Full Text] [Related]